Press releases
- Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board Declares Quarterly Dividend
- Bruker Announces Acquisition of ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions
- Bruker Reports First Quarter 2023 Financial Results
- Bruker Announces Date and Time of First Quarter 2023 Earnings Release and Webcast
- Bruker Advances NMR Magnet Portfolio, Innovates in Industrial Solutions
- Bruker Introduces New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper®, and a Novel LiquidArray® Gastrointestinal Syndromic Panel
- PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics
- Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform
- Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK
- Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 1,372.36 |
Average volume | -- |
---|---|
Shares outstanding | 146.73m |
Free float | 98.87m |
P/E (TTM) | 34.09 |
Market cap | 10.51bn USD |
EPS (TTM) | 2.10 USD |
Annual div (ADY) | 3.53 MXN |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Feb 28 2023 |
Div pay-date | Mar 17 2023 |
Next div ex-date | May 31 2023 |
Next div pay-date | Jun 16 2023 |
Data delayed at least 20 minutes, as of Feb 14 2022 11:30 GMT.
More ▼